Cantor Fitzgerald Initiates Coverage On Eikon Therapeutics with Overweight Rating
Benzinga Newsdesk 8 months ago
NewsInitiationAnalyst Ratings
Cantor Fitzgerald analyst Imogen Mansfield initiates coverage on Eikon Therapeutics (NASDAQ:EIKN) with a Overweight rating.
Cantor Fitzgerald analyst Imogen Mansfield initiates coverage on Eikon Therapeutics (NASDAQ:EIKN) with a Overweight rating.